Point72 Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Point72 Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.2M	Buy	1,021,808 +818,733	+403%	+$13M	0.02%	1015
2025 Q4	$3.3M	Sell	203,075 -116,396	-36%	-$1.9M	﹤0.01%	2135
2025 Q3	$4.78M	Sell	319,471 -1,054,452	-77%	-$12.8M	0.01%	1089
2025 Q2	$16M	Buy	+1,373,923	New	+$12.5M	0.03%	576
2025 Q1	–	Sell	-937,331	Closed	-$5.62M	–	1994
2024 Q4	$5.62M	Buy	937,331 +441,839	+89%	+$2.44M	0.01%	911
2024 Q3	$2.54M	Buy	+495,492	New	+$2.16M	0.01%	1097
2024 Q2	–	Sell	-274,700	Closed	-$882K	–	1804
2024 Q1	$882K	Sell	274,700 -3,447,800	-93%	-$13.3M	﹤0.01%	1489
2023 Q4	$18.2M	Sell	3,722,500 -1,990,800	-35%	-$9.08M	0.04%	465
2023 Q3	$31.1M	Buy	+5,713,300	New	+$37.8M	0.09%	286
2019 Q3	–	Sell	-50,000	Closed	-$2.42M	–	1096
2019 Q2	$2.42M	Buy	+50,000	New	+$2.21M	0.01%	631

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Asset Management's ADPT Position: Q1 2026 in Review

Point72 Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 403% in Q1 2026, buying an estimated $13M and bringing the position to 1,021,808 shares worth $14.2M. The position accounts for 0.02% of the portfolio, ranked #1015.

Point72 Asset Management first reported a position in ADPT in Q2 2019 and has held it in 10 quarters since. The position peaked at $31.1M in Q3 2023. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Point72 Asset Management held 1,021,808 shares of Adaptive Biotechnologies worth $14.2M as of Q1 2026.
Point72 Asset Management bought 818,733 Adaptive Biotechnologies shares in Q1 2026, an estimated $13M.
Adaptive Biotechnologies made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #1015 holding.
Point72 Asset Management first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 10 quarters since.
Point72 Asset Management's Adaptive Biotechnologies position peaked at $31.1M in Q3 2023.
295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.